Moleculin Biotech INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersHouston, TX
US patents4
SAM.gov UEIJAJBNQA7FJB6
CAGE code8JSV5
Incorporated inDE
LEI549300IB1TLJZCHEO353
Brands
Hex2_Final
Hex1_v2
MBRX_Pipe 10.29.24This company sells these brands.
- product candidates
- tumors
- viruses
- MIRACLE
- acute myeloid leukemia
- WP1122
- WP1066
- soft tissue sarcoma
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2024–2025, 4 of them in the five years to SEP 2025.
Pharmaceuticals 4
- Method of reconstituting liposomal annamycinUS 12,257,262 · granted MAR 25, 2025
- Preparation of preliposomal Annamycin lyophilizateUS 12,257,261 · granted MAR 25, 2025
- Method of reconstituting liposomal annamycinUS 11,980,634 · granted MAY 14, 2024
- Preparation of preliposomal annamycin lyophilizateUS 11,951,118 · granted APR 9, 2024
Granted to Moleculin Biotech, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Moleculin Biotech INC | Houston | TX | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.